Picture of Fabino Enterprises logo

543444 Fabino Enterprises Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m-12.58%
3m-16.06%
6m+0.97%
1yr-14.24%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-27.34%
50d MA-7.91%
200d MA-11.4%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.33
Price to Tang. Book1.33
Price to Free Cashflown/a
Price to Sales1.31
EV to EBITDA1,103.14

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-0.75%
Return on Equity-0.3%
Operating Margin-1.16%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Fabino Enterprises EPS forecast chart

Profile Summary

Fabino Enterprises Limited is an India-based pharmaceutical company. The Company specializes in sourcing active pharmaceutical ingredients (APIs) and offers a range of allopathic tablets and injectables. The Company's products include 21 No Tea, AMOXRAG-625, Astrid Syrup, Aur D3 Capsules, Aurceta AM, Aurcis-Forte, Aurifox OZ, Aurimor Gold, Aurimor plus, Aurirug 200, Aurirug O, Aurnim Plus, Aurstin 250, Aurstin 500, Aurzyme-Syrup, Ayush Kadha, Calogrip, Cefga 1gm, Cekal Forte, Ceporag O, Coptec Capsules, Coptec-syrup, Cough-Free, Dexrog Syrup, Dicarag Gel, Dicpa, Doref DS, Doref M, Dr-DSR, DStoren-Syrup, Ecstasy Tilla Oil, F Plexus A, Fab Cafe, Fablactin, Fabovit, and Fabpara, Fabvit C, Fabvita- Malt Protein, FABZYM CAPSULE, Giloy Power, Glucose, Guava Juice, Iorag-XT, Keepshine Hair Oil, Keepshine Shampoo, Lychee Juice, M-Sharp-Brain-tonic, Mango Juice, Massage Oil, Mefdic, Misar-40, and Misar-H.

Directors

    Last Annual
    March 31st, 2024
    Last Interim
    September 30th, 2024
    Incorporated
    October 27th, 2011
    Public Since
    January 13th, 2022
    No. of Employees
    11
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    in flag iconBombay Stock Exchange
    Shares in Issue
    2,100,000
    Blurred out image of a map
    Address
    B-Wing, NEW DELHI, 110085
    Web
    https://www.fabinolife.com/
    Phone
    Auditors
    D. G. M. S & Co

    543444 Share Price Performance

    Similar to 543444

    Picture of Aayush Wellness logo

    Aayush Wellness

    in flag iconBombay Stock Exchange

    Picture of Achyut Healthcare logo

    Achyut Healthcare

    in flag iconBombay Stock Exchange

    Picture of Adline Chem Lab logo

    Adline Chem Lab

    in flag iconBombay Stock Exchange

    Picture of MPS Pharmaa logo

    MPS Pharmaa

    in flag iconBombay Stock Exchange

    Picture of Albert David logo

    Albert David

    in flag iconBombay Stock Exchange

    FAQ